Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
UBS
QuintilesIMS
Healthtrust
Daiichi Sankyo
Mallinckrodt
US Army
Johnson and Johnson

Generated: June 24, 2018

DrugPatentWatch Database Preview

AZACITIDINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for AZACITIDINE
Pharmacology for AZACITIDINE
Medical Subject Heading (MeSH) Categories for AZACITIDINE
Synonyms for AZACITIDINE
1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-amino-1,3,5-tri azin-2-one
1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-
124679-EP2270008A1
124679-EP2292617A1
124679-EP2295426A1
124679-EP2295427A1
2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one
320-67-2
320A672
33795-EP2275420A1
33795-EP2295055A2
33795-EP2295416A2
33795-EP2298748A2
33795-EP2298764A1
33795-EP2298765A1
33795-EP2305642A2
33795-EP2311453A1
33795-EP2311840A1
4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-
4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one
4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one; Ladakamycin
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one
4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one
4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one
4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one
5 Azacytidine
5 AZC
5-AC
5-aza-CR
5-AZAC
5-azacitidine
5-azacytidine
5-Azacytidine, >=98% (HPLC)
5-Azacytidine, Hybri-Max(TM), gamma-irradiated, lyophilized powder, BioXtra, suitable for hybridoma
5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine
5-azacytidine;Mylosar;Ladakamycin;Vidaza
5-AZCR
5AE
5AzaC
A 2385
A5777
AB2000290
ABP001093
AC1L1T1Y
AK142815
AKOS015896938
AM83944
Antibiotic U 18496
ANW-27256
API0003444
AS-13697
AX8008347
Azacitidina
Azacitidina [INN-Spanish]
Azacitidine (JAN/USAN/INN)
Azacitidine (Vidaza)
Azacitidine [USAN:INN:BAN]
Azacitidine [USAN:INN]
Azacitidine, Pharmaceutical Secondary Standard; Certified Reference Material
Azacitidine, United States Pharmacopeia (USP) Reference Standard
Azacitidinum
Azacitidinum [INN-Latin]
Azacytidine
BCBcMAP01_000083
BDBM50424715
BRN 0620461
BSPBio_003157
C-14788
C11262
CAS-320-67-2
CC-21195
CCG-39046
CCRIS 60
CHEBI:2038
CHEMBL1489
cMAP_000082
CPD000857239
CS-1287
CTK1C2919
D03021
D09FAZ
DB-006955
DB00928
DivK1c_000125
DSSTox_CID_116
DSSTox_GSID_20116
DSSTox_RID_75378
DTXSID9020116
EBD145507
EINECS 206-280-2
EOS113
EU-0100035
FT-0081170
FT-0601307
GTPL6796
HMS1921J22
HMS2092D08
HMS2231F15
HMS3259D19
HMS3260G11
HMS500G07
HSDB 6879
HY-10586
IDI1_000125
InChI=1/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
J-700085
J10124
Jsp005945
KB-41704
KBio1_000125
KBio2_001742
KBio2_002556
KBio2_004310
KBio2_005124
KBio2_006878
KBio2_007692
KBio3_002657
KBio3_003034
KBioGR_001444
KBioGR_002556
KBioSS_001742
KBioSS_002565
KSC222S1T
Ladakamycin
Ledakamycin
Lopac0_000035
LP00035
LS-1189
M801H13NRU
MCULE-8318770472
MFCD00006539
MLS001333121
MLS001333122
MLS002153249
MLS002548894
MolMap_000062
MolPort-003-665-502
mylo sar
Mylosar
NC00672
NCGC00090851-01
NCGC00090851-02
NCGC00090851-03
NCGC00090851-04
NCGC00090851-05
NCGC00090851-06
NCGC00090851-07
NCGC00090851-08
NCGC00090851-10
NCGC00178234-01
NCGC00256541-01
NCGC00260720-01
NCI-C01569
NINDS_000125
NMUSYJAQQFHJEW-KVTDHHQDSA-
NMUSYJAQQFHJEW-KVTDHHQDSA-N
NS-17
NSC 102816
NSC-102816
NSC-758186
NSC102816
NSC758186
NU000206
NU004636
NU004637
Pharmakon1600-01502111
Pharmion Brand of Azacitidine
PubChem14167
pyrimidine antimetabolite: inhibits nucleic acid replication
RP28647
RTR-013523
s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-
s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI)
S-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-(8CI)
s1782
SAM002264595
SBB066305
SC-09078
SCHEMBL3741
SL-000003
SMR000857239
SPBio_000892
Spectrum_001262
SPECTRUM1502111
Spectrum2_000786
Spectrum3_001509
Spectrum4_000922
Spectrum5_001166
SR-01000075662
SR-01000075662-1
SRI-10756_10
SRI-10756_12
ST056940
ST24044344
TL80073599
Tox21_111032
Tox21_111032_1
Tox21_302985
Tox21_500035
TR-013523
U 18496
U-18,496
U-18496
UNII-M801H13NRU
Vidaz (TN)
Vidaza
Vidaza (TN)
wr 183027
WR-183027
Z1522566611
ZINC3861768

US Patents and Regulatory Information for AZACITIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Llc AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 208216-001 Apr 29, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 204949-001 Apr 28, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cipla Ltd AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 209540-001 May 4, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 201537-001 Sep 16, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Covington
Express Scripts
Argus Health
Moodys
Farmers Insurance
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.